ALKS

Alkermes Plc

A biopharmaceutical company that develops and sells medicines for central nervous system and addiction disorders, including Aristada for schizophrenia and Vivitrol for alcohol and opioid dependence. The name Alkermes comes from the alchemical word for a red dye made from insects, nodding to the firm's roots in drug-delivery technology. Founded in 1987 and headquartered in Dublin, it grew through the merger of two drug-delivery pioneers and now lists its shares on Wall Street.

CUSIP: G01767105HealthcareUS

Ownership Activity Financials Filings

ALKS

ALKS

Entry into a Material Definitive Agreement

Results of Operations and Financial Condition

Termination of a Material Definitive Agreement

Regulation FD Disclosure

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Regulation FD Disclosure

Results of Operations and Financial Condition

Results of Operations and Financial Condition